PDF hosted at the Radboud Repository of the Radboud University Nijmegen
|
|
- Johnathan Pearson
- 5 years ago
- Views:
Transcription
1 PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. Please be advised that this information was generated on and may be subject to change.
2 The Netherlands JOURNAL OF MEDICINE E LSE V IER Netherlands Journal of Medicine 47 (1995) Review Nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease: who should be treated and how? Y.F. H eijdra *, P.N.R. Dekhuijzen, P J.E. Vos, H.Th.M. Folgering, C.L.A. van Herwaarden Department of Pulmonary Diseases\ University of Nijmegen, Medical Centre Dekkerswald, P.0. Box 9001, 6560 GB Groesbeek, Netherlands Received 8 June 1995; revised 4 August 1995; accepted 23 August 1995 Keywords: COPD; Nocturnal hypoxaemia; Treatment 1. Introduction C hronic obstructive pulm onary disease (COPD) is characterised by progressive loss of lung function and oxygen uptake capacity. As a consequence, extensive morbidity and mortality do occur in these patients due to complications of hypoxaemia such as polycythaemia, pulmonary hypertension, cor pulmonale and cardiac arrhythmias. In the course of the disease, periods with arterial oxygen desaturations may first occur during REM sleep [1], due to hypoventilation [2]. Prospective studies estimate that this occurs in % of the patients with COPD who are normoxaemic during the day, depending on the definition of desaturation and the severity of the disease [1,3,4]. Treatm ent modalities to improve nocturnal saturation in these patients include supplemental oxygen, respiration-stimulating agents, assisted ventilation and training of the respiratory muscles. In this article we will discuss some aspects of * Tel.: ( ) 59911; fax: ( ) the breathing disorders during sleep that may occur in patients with COPD and the different treatment modalities. 2. Diagnosis 2.1. Polysomnography Nocturnal breathing disorders and their underlying mechanisms can be assessed by polysomnography. During the night arterial oxygen saturation, carbon dioxide tension measured in respiratory air, arterially or transcutaneously, thoracoabdominal movements, oscillation in oesophageal pressure and sleep stages are recorded. Sleep stages are recorded to define the adequancy of sleep, i.e. is there enough sleep to be representative, and conformation of REM sleep to catch the presence of REM sleep-related phenomena [5]. When analysing polysomnography records, several irregular breathing patterns can be distinguished. Central apnoea is defined as the absence of P C 0 2 oscillations or oro-nasal airflow for at least 10 s, in combination with absent chest wall /95/$ Elsevier Science B.V. All rights reserved SSDI (95)
3 Y.F. Heijdra et a l /Netherlands Journal o f Medicine 47 (1995) movements or oesophageal pressure swings. Obstructive apnoea is defined as the absence of P C 0 2 oscillations or oro-nasal airflow for at least 10 s, in combination with a normal or decreased chest wall movement. Hypopnoea is defined as an or generalised fatigue [8], an HCVR below min" 1 kpa~* [4] or low maximal inspiratory pressures (females < 5.0 kpa, males < 7.5 kpa) [9]. episode of alveolar hypoventilation of at least 10 s detected by an increase in P C 0 2. Central hypopnoea is caused by a decrease in central ventilatory drive, and ideally it should be deduced from a parameter that measures ventilatory drive more or less directly. Integrated respiratory muscle EMG or oesophageal pressure oscillations are such parameters. Indirect parameters of a decrease in ventilatory drive, such as movements of the thoracic wall, should be interpreted with extreme caution. The term central hypoventilation is often used to indicate hypoventilation of a nonobstructive origin, such as respiratory muscle failure, although the latter is no central problem in the strict sense. Obstructive hypopnoea is associated with a normal or even increased central ventilatory drive and decreased ventilation. A combination of central and obstructive breathing disorders may also be present. These irregular breathing patterns occur most frequently during REM sleep. Several studies have tried to find daytime parameters to predict nocturnal saturation in patients with COPD, because nocturnal hypoxaemia caused by central hypopnoea is often symptomless. Although, polycythaemia, pulmonary hypertension, cor pulmonale, morning headache or generalised fatigue indicate the presence of severe disturbances. Daytime S a 0 2 (r = 0.87), P ac 0 2 ( r = -0.73), F E ^ (r = 0.61), the hypercapnie ventilatory response (HCVR) (r = 0.41) and maximal inspiratory mouth and transdiaphragmatic pressures (r = 0.65 and 0.53, respectively) are related to nocturnal saturation in groups of patients [4,6,7]. However, none of these variables is able to predict nocturnal saturation in the individual patient, precisely enough to replace polysomnography. Therefore, polysomnography or a screening oximetry is advised in patients with a daytime P a 0 2 between kpa combined with one of the following disorders: polycythaemia, pulmonary hypertension, cor pulmonale, PaCOa > 45 mmhg, morning headache 3. Mechanisms involved in the occurrence of nocturnal desaturations In many patients with COPD, transient decreases in nocturnal arterial oxygen saturation occur. This may be caused by a variety of factors. The importance of these factors will be outlined below. Hypoventilation ( central hypopnoea ); During sleep, ventilation is reduced in normal subjects and in patients with COPD [3]. This hypoventilation is most severe during REM sleep. The cause of this phenomenon is not fully understood but may be related to a decrease in brainstem respiratory activity, diminished respiratory responses to hypoxia and hypercapnia during REM sleep, and a loss of inspiratory activity of intercostal muscles and accessory respiratory muscles. The latter is due to the REM-sleep-related supraspinal inhibition of the gamma motor neuron drive. «Since the gamma motoneuron innervation of the diaphragm is sparse, this muscle is relatively spared. These changes occur in patients with COPD as well as in healthy subjects, but the consequences are worse in the first group. Firstly, patients with COPD often have somewhat lowered arterial oxygen tensions awake. The starting position on the oxygen saturation curve is closer to the steep part, so a small drop in P a 0 2 during the night causes a large fall in S a 0 2. Secondly, the flattened diaphragm cannot compensate for the decreased activity of intercostal and accessory muscles during REM sleep. Thirdly, desaturating patients have a larger decrease in functional residual capacity during hypopnoea [2]. Finally, the ventilatory responses in some patients with COPD during wakefulness are already lowered, thus further contributing to the degree of nocturnal desaturations [4]. Ventilation / perfusion inequality: Previously, this was considered as the major cause of REM- sleep-related hypoxaemia in patients with COPD
4 298 YF. Heijdra et a l / Netherlands Journal o f Medicine 47 (1995) [3]. However, these studies were based on the assumption that there is a steady state of gas transfer, which does not exist during REM sleep [10]. It is inevitable, though, that hypoventiiation during REM sleep is accompanied by some alteration in ventilation/perfusion matching. Abnormal hypercapnic and hypoxic responses: Ventilatory responses during wakefulness to hypercapnia and hypoxia seem to be lower in hypoxic patients [3], Obstructive sleep apnoea / hypopnoea syndrome (OSAHS): OSAHS, defined as a sleeping disorder in which obstructive apnoea/hypopnoea events occur more than 10 times per sleeping hour, may affect 1-4% of the general population [3]. Thus, a similar percentage of patients with COPD may also suffer from OSAHS, but the prevalence is most probably not higher than in the general population. 4. Consequences of nocturnal hypoxaemia When desaturations are severe and result in nocturnal hypoxaemia, side-effects may occur. Nocturnal hypoxaemia is associated with pulmonary hypertension [11-14], which causes cor pulmonale [15,16], Furthermore, polycythaemia may exist [17]. Cardiac arrhythmia is an uncommon complication, but premature ventricular complexes, bradycardia and tachycardia have been described [18]. In the study of Levi-Valensi and colleagues [11] a correlation (r = 0.33) was found between the total duration of saturation dips and pulmonary hypertension in 40 patients with COPD and a daytime P a 0 2 between kpa (60-70 mmhg). Pulmonary hypertension was only present in 6 out of 18 patients who desaturated. These findings are in line with the data published by Fletcher and co-workers [12]. These authors found that the systolic pulmonary arterial pressure was significantly higher in desaturating (n = 36) than in non-desaturating (n = 13) patients with COPD and with a daytime P a 0 2 > 8 kpa (60 mmhg) (33 versus 26 mmhg, p < 0.01). In the study of Boysen and colleaques [13] the effects of hypoxaemic episodes on the pulmonary artery pressure (Pap) during the night were studied in 4 patients with COPD. All nocturnal episodes of desaturations were accompanied by elevations in the Pap. Low flow oxygen abolished the drops in arterial oxygen saturation and no elevations in the Pap were observed. Weitzenblum and co-workers [14] investigated prospectively the changes in P a 0 2 and Pap in 93 hypoxaemic patients with severe COPD for at least 5 years. In 27 patients an increase > 5 mmhg in the Pap was observed. Only in this patient group was a marked worsening of the P a 0 2 seen, which was not observed in the remaining 66 patients. There was a significant correlation between the change in Pap and P a 0 2 ( r = 0.50, p <0.001). All these studies suggest that nocturnal hypoxaemia is associated with the development and progression of pulmonary hypertension. The relationship between daytime or nocturnal hypoxaemia and cor pulmonale was studied by Midgren and colleagues [16]. Seven of the 21 included patients with COPD had suffered from right ventricular failure at least once. They had lower P a 0 2 and higher P ac 0 2 levels than the patients without a history of right heart failure. They were more hypoxaemic during the night. In the group as a whole no correlations were found between daytime oxygenation and right ventricular hypertrophy. However, oxygen saturation during the night and right ventricular hypertrophy were inversely related (r = , p < 0.01). Therefore, in normoxic patients during the day but with signs of right heart failure a polysomnography is advised. The effects of nocturnal hypoxaemia on survival are not clear yet. One study is available in which survival in desaturating and non-desaturating patients is compared [1]. One hundred and sixty-nine patients with COPD and a FEVt of 35% predicted, who were all normoxaemic (daytime PaO 2 > 8.0 kpa [60 mmhg]), were investigated. Desaturating patients had a worse survival than non-desaturating patients (mean survival 2.9 [1.7] and 3.7 [1.7]) years, respectively). Also, 5-year survival was significantly better in the non-desaturating group (after stratification for oxygen suppletion). However, this was a retrospective multicentre study in which patients were included who were already being treated with oxygen.
5 Y.F. Heijdra et al. /Netherlands Journal o f Medicine 47 (1995) Treatment of nocturnal hypoxaemia 5.1, Supplemental oxygen Studies on the effects of oxygen have only been performed in patients who were also hypoxaemic during the day. In these studies an improvement of the quality of life [19], some reversal of ECG changes (less right axis deviation or the loss of the finding of p-pulmonale [19]) and a decrease in the pulmonary artery pressure combined with an increase in cardiac output [20] were observed. Supplemental oxygen during the night can be given safely because it improves nocturnal oxygenation with only a small rise in P ac 02 [21]. Nocturnal oxygen supply should be titrated individually during a full night and should be controlled by oximetry. The mean nocturnal arterial oxygen saturation should be more than 90% [22] Ventilatory stimulants Stimulating agents may be considered if any reserve-capacity of the ventilatory pump is present. The progestogens medroxyprogesterone acetate and chlormadione acetate increased daytime P a 0 2 and decreased PaC0 2, but the effects on nocturnal saturation were marginal or absent in the whole group of patients. Nevertheless, for the individual patient, chlormadione acetate may have a substantially positive effect on day- and nighttime blood gas values [23,24]. Acetazolamide, a carbonic anhydrase inhibitor, stimulates ventilation presumably by inducing metabolic acidosis. In a 1-week double-blind, placebo-controlled study it caused an improvement in the mean daytime P a 0 2 of 1.9 kpa (14 mmhg) and in the mean nocturnal saturation of 4% [24]. However, acetazolamide may be ineffective in some patients. Daytime parameters, however, failed to select the non-responders. Recently, Mulloy et al. [25] showed in a 3-week double-blind, placebocontrolled study that theophylline improved gas exchange during sleep in 10 patients with severe COPD. The mean S a 0 2 asleep improved by 2% while the mean transcutaneously measured P C 0 2 asleep decreased by 0.5 kpa (4 mmhg). Loop diuretics have an adverse effect on nocturnal saturation since they can result in a metabolic alkalosis and blunt the respiratory drive [15] Assisted ventilation Continuous positive pressure ventilation during the night, administered through a nasal mask, can effectively reduce inspiratory muscle effort during sleep, but S a 0 2 and transcutaneously measured P C 0 2 were unaffected [26]. The effects of nasal intermittent positive pressure ventilation were described in an uncontrolled study by Carroll and co-workers [27]. They showed in 4 hypoxaemic patients with COPD and with a mean FEVj of 19% of the predicted value that daytime P a 0 2 did not change significantly while daytime P ac 0 2 decreased by 1.1 kpa (14.3 mmhg). Oxygenation during the night improved. This was shown by a decrease in the time spent below 90% S a 0 2 from 100 to 40% of the total monitoring time. However, the patients slept less well, as shown by a decrease in REM sleep from 12 to 5% of the monitoring time Training o f the respiratory muscles Target-flow inspiratory muscle training (TF- IMT) is the most recently described form of therapy [28]. During 10 weeks, 10 patients with COPD underwent TF-IMT at 60% of their maximal inspiratory mouth pressure (P Imax) and 10 control patients with COPD received sham TF-IMT at 10% of PI miui Two times a day patients trained on an incentive flow meter with an added resistance for 15 min. P Imax, maximal inspiratory transdiaphragmatic pressure (Pdi), and respiratory muscle endurance improved significantly in the 60% training group. No changes were found in the sham training group. The improved respiratory muscle function resulted in a mean increase in mean nocturnal saturation by 2% (p = 0.01); the most pronounced improvements (up to 7%) were found in patients with the lowest nocturnal saturations. 6. Clinical consequences and recommendations Although positive effects of the different forms of therapy on nocturnal saturation have been described, no placebo-controlled studies have
6 300 Y. F. Heìjdra et al. / Netherlands Journal of Medicine 47 (1995) Table 1 Treatment of nocturnal hypoxaemia Daytime Nocturnal Treatment oxygenation oxygenation modality P a kpa S a 0 2 <90% Continuous (55-60 mmhg) oxygen combined with Ht > 55% or pulmonary artery pressure > 3 kpa or cor pulmonale P a 0 2 > 7.3 kpa S a 0 2 <85% Oxygen during (55 mmhg) ( > 2 h) the night P a 0 2 > 7.3 kpa S a % Acetazolamide» (55 mmhg) theophyllines, progestogens, IMT P a 0 2 partial arterial oxygen tension; S a0 2 ~ arterial oxygen saturation; Ht = haematocrit; IMT inspiratory muscle training. been published on the effects on pulmonary artery pressure, cor pulmonale and survival. So far it has not been recommended, therefore, to prescribe oxygen to patients with mild nocturnal hypoxaemia only, since it is an expensive form of therapy. An exception is made for patients with severe hypoxaemia (S a0 2 < 85%) for more than 2 hours while sleeping, because it is unlikely that such episodes are harmless [22]. Acetazolamide, progestogens, theophyllines and inspiratory muscle training are modalities that can be used to treat nocturnal hypoxaemia, but their effects on the occurrence of complications in the long term are not known. Based upon the above-mentioned considerations, nocturnal hypoxaemia (S a0 2 < 90%) in patients with COPD should be treated in the following way (Table 1). Supplemental oxygen for as close to 24 h /d ay as is possible [29] should be administered if nocturnal hypoxaemia is present in combination with a daytime P a 0 2 between kpa (55-60 mmhg) with evidence of poly- cythaemia (Ht > 55%) or pulmonary hypertension (mean pulmonary artery pressure > 3 kpa [20 mmhg]) or clinical signs of cor pulmonale [22,30]. Nocturnal oxygen therapy may be considered in patients with severe episodes of hypoxaemia (S a 0 2 < 85%) for more than 2 hours during the night [22]. The oxygen dose should be sufficient to raise the saturation above 90% [22]. Acetazolamide, progestogens, theophylline and respiratory muscle training may be considered to treat patients with mild hypoxaemia only during the night. Polysomnography should be used for diagnosing nocturnal hypoxaemia, its underlying mechanisms, and for establishing the presence of REM sleep in the diagnostic night. Oximetry can be used for screening purposes, and for titrating the required amount of supplemental nocturnal oxygen. References [1] Fletcher EC, Donner CF, Midgren B, et al. Survival in COPD patients with a daytime P a 0 2 > 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest 1992;101: [2] Hudgel DW, Martin RJ, Capehart M, Johnson B, Hill P. Contribution of hypoventilation to sleep oxygen desaturation in chronic obstructive pulmonary disease. J Appl Physiol 1983;55: [3] Douglas NJ, Flenley D C Breathing during sleep in patients with obstructive lung disease. Am Rev Respir Dis 1990;141: [4] Vos PJE, FoJgering HThM, van Herwaarden CLA. Predictors for nocturnal hypoxemia (mean S a 0 2 < 90%) in normoxic and mildly hypoxic patients with COPD. Eur Respir J 1995;8: [5] Stradling JR. Sleep studies for sleep-related breathing disorders. J Sleep Res 1992;1: [6] Connaughton JJ, Catterall JR> Elton RA, Stradling JR, Douglas NJ. Do sleep studies contribute to the management of patients with severe chronic obstructive pulmonary disease? Am Rev Respir Dis 1988;138: [7] Heijdra YF, Dekhuijzen PNR, van Herwaarden CLA, Folgering HThM. Nocturnal saturation and respiratory muscle function in patients with chronic obstructive pulmonary disease. Thorax 1995;50: [8] American Thoracic Society, indications and standards for cardiopulmonary sleep studies. Am Rev Respir Dis 1989;139: [9] Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99: [10] Millman RP, Knight H, Kline LR, Shore ET, Chung D-CC, Pack AI. Changes in compartmental ventilation in association with eye movements during REM sleep. J Appl Physiol 1988;65: [11] Levi-Valensi P, Weitzenblum E, Rida Z, et al. Sleep-related oxygen desaturation and daytime pulmonary haemodynamics in COPD patients. Eur Respir J 1992;5:
7 Y.F. Heijdra et al. / Netherlands Journal o f Medicine 47 (1995) [12] Fletcher EC, Luckett RA, Miller T, Costarangos C, Kutka N, Fletcher JG. Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleep. Chest 1989;95: [13] Boysen PG, Block AJ, Wynne JW, Hunt LA, Flick MR. Nocturnal pulmonary hypertension in patients with chronic obstructive pulm onary disease. Chest 1979;76: [14] Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Hirth C, Roegel E, Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984;130: [15] Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulm onary disease. Chest 1991;99: [16] Midgren B, White T, Petersson K, Bryhn M, Airikkala P, Elmqvist D. Nocturnal hypoxaemia and cor pulmonale in severe chronic lung disease. Bull Eur Physiopathol Respir 1985;21: [17] Weil JV, Jamieson G, Brown DW, Grover RF, Balchum OJ, Murray JF. The red cell mass-arterial oxygen relationship in normal man. J Clin Invest 1968;47: [18] Tirlapur VG, Mir MA. Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease. N Engl J Med 1982;306: [19] Stewart BN, Hood Cl, Block AJ. Long-term results of continuous oxygen therapy at sea level. Chest 1975;68: [20] Fletcher EC, Levin DC. Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short and long-term oxygen. Chest 1984;85:6-14. [21] Goldstein RS, Ramcharan ChBV, Bowes G, McNicholas WT, Bradley D, Phillipson EA. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med 1984;310: [22] American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136: , [23] Daskalopoulou E, Patakas D, Tsara V, Zoglopitis F, Maniki E. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease. Thorax 1990;45: [24] Vos PJE, Folgering HThM, Boo de ThM, Lemmens WJGM, van Herwaarden CLA. Effects of chlormadione acetate and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 1994;7: [25] Mulloy E, McNicholas WT. Theophylline improves gas exchange during rest, exercise and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1993;148: [26] Petrof BJ, Kimoff RJ, Levy RD, Cosio MG, Gottfried SB. Nasal continuous positive airway pressure facilitates respiratory muscle function during sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143: [27] Carroll N, Branthwaite MA. Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation. Thorax 1988;43: [28] Heijdra YF, Dekhuijzen PNR, van Herwaarden CLA, Folgering HThM. Nocturnal saturation improves by target-flow inspiratory muscle training in patients with COPD. Am J Resp Crit Care Med 1995;in press. [29] Nocturnal Oygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93: [30] Kampelmacher MJ, van Kesteren RG, Deenstra M, Douze JMC, Lammers J-WJ. Long-term oxygen therapy. Neth J Med 1994;44: >
THE EFFECTS OF MEDROXYPROGESTERONE ACETATE AND ACETAZOLAMIDE ON THE NOCTURNAL OXYGEN SATURATION IN COPD PATIENTS
THE EFFECTS OF MEDROXYPROGESTERONE ACETATE AND ACETAZOLAMIDE ON THE NOCTURNAL OXYGEN SATURATION IN COPD PATIENTS Wagenaar, M., Vos, P., Heijdra, Y., Herwaarden, C. van, Folgering, H. Departement of Pulmonary
More informationP.J.E. Vos*, H. Th.M. Folgering*, Th. M. de Boo**, W.J.G.M. Lemmens**, C.L.A. van Herwaarden*
Eur Respir J, 1994, 7, 850 855 DOI: 10.1183/09031936.94.07050850 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1994 European Respiratory Journal ISSN 0903-1936 Effects of chlormadinone
More informationSleep-related O 2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia
Eur Respir J 1997; 10: 1730 1735 DOI: 10.1183/09031936.97.10081730 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Sleep-related O 2 desaturation
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/23077
More informationPatients with COPD run a risk of developing. Underestimation of Nocturnal Hypoxemia Due to Monitoring Conditions in Patients With COPD*
Underestimation of Nocturnal Hypoxemia Due to Monitoring Conditions in Patients With COPD* Folkert Brijker, MD; Frank J. J. van den Elshout, MD, PhD; Yvonne F. Heijdra, MD, PhD; and Hans Th. M. Folgering,
More information(To be filled by the treating physician)
CERTIFICATE OF MEDICAL NECESSITY TO BE ISSUED TO CGHS BENEFICIAREIS BEING PRESCRIBED BILEVEL CONTINUOUS POSITIVE AIRWAY PRESSURE (BI-LEVEL CPAP) / BI-LEVEL VENTILATORY SUPPORT SYSTEM Certification Type
More informationOriginal Article. Keywords: Sleep, REM; Pulmonary disease, chronic obstructive; Anoxemia; Spirometry; Wakefulness
Nocturnal desaturation: predictors and the effect on sleep patterns in patients with chronic obstructive pulmonary disease and concomitant mild daytime hypoxemia Original Article Nocturnal desaturation:
More informationSleep has well-recognized effects on breathing,
Impact of Sleep in COPD* Walter T. McNicholas, MD, FCCP Sleep has well-recognized effects on breathing, including changes in central respiratory control, airways resistance, and muscular contractility,
More informationN. Soguel Schenkel, L. Burdet, B. de Muralt, J.W. Fitting
Eur Respir J, 1996, 9, 2584 2589 DOI: 10.1183/09031936.96.09122584 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Oxygen saturation during
More informationA randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients
Eur Respir J 1999; 14: 1002±1008 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 A randomized trial of nocturnal oxygen therapy in chronic
More informationBi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients
Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients Objectives Describe nocturnal ventilation characteristics that may indicate underlying conditions and benefits of bilevel therapy for specific
More informationOSA and COPD: What happens when the two OVERLAP?
2011 ISRC Seminar 1 COPD OSA OSA and COPD: What happens when the two OVERLAP? Overlap Syndrome 1 OSA and COPD: What happens when the two OVERLAP? ResMed 10 JAN Global leaders in sleep and respiratory medicine
More informationCauses and Consequences of Respiratory Centre Depression and Hypoventilation
Causes and Consequences of Respiratory Centre Depression and Hypoventilation Lou Irving Director Respiratory and Sleep Medicine, RMH louis.irving@mh.org.au Capacity of the Respiratory System At rest During
More informationmore than 50% of adults weigh more than 20% above optimum
In the US: more than 50% of adults weigh more than 20% above optimum >30 kg m -2 obesity >40 kg m -2 morbid obesity BMI = weight(kg) / height(m 2 ) Pounds X 2.2 Inches divided by 39, squared From 2000
More informationCombined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients
Eur Respir J 2002; 20: 1130 1137 DOI: 10.1183/09031936.02.00016402 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Combined treatment with
More informationControl of nocturnal hypoventilation by nasal
Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation N CARROLL, M A BRANTHWAITE From Brompton Hospital, London Thorax 1988;43:349-353 ABSTRACT Ten patients with respiratory
More informationArousal detection in sleep
Arousal detection in sleep FW BES, H KUYKENS AND A KUMAR MEDCARE AUTOMATION, OTTHO HELDRINGSTRAAT 27 1066XT AMSTERDAM, THE NETHERLANDS Introduction Arousals are part of normal sleep. They become pathological
More informationImpact of sleep in respiratory failure
Eur Respir J 1997; 10: 920 933 DOI: 10.1183/09031936.97.10040920 Printed in UK - all rights reserved Impact of sleep in respiratory failure Copyright ERS Journals Ltd 1997 European Respiratory Journal
More informationAlbert L. Rafanan, MD; Joseph A. Golish, MD, FCCP; Dudley S. Dinner, MD; L. Kathleen Hague, RN; and Alejandro C. Arroliga, MD, FCCP
Nocturnal Hypoxemia Is Common in Primary Pulmonary Hypertension* Albert L. Rafanan, MD; Joseph A. Golish, MD, FCCP; Dudley S. Dinner, MD; L. Kathleen Hague, RN; and Alejandro C. Arroliga, MD, FCCP Study
More informationA.A. Okubadejo*, E.A. Paul*, P.W. Jones**, J.A. Wedzicha
Eur Respir J, 1996, 9, 2335 2339 DOI: 10.1183/09031936.96.09112335 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Does long-term oxygen
More informationSleep Disordered Breathing: Beware Snoring! Dr T A McDonagh Consultant Cardiologist Royal Brompton Hospital London. UK
Sleep Disordered Breathing: Beware Snoring! Dr T A McDonagh Consultant Cardiologist Royal Brompton Hospital London. UK Sleep Disordered Breathing in CHF Erratic breathing during sleep known for years e.g.
More informationRebecca Mason. Respiratory Consultant RUH Bath
NIV in motor neurone disease Rebecca Mason Respiratory Consultant RUH Bath NIV in motor neurone disease Why does MND affect the Respiratory System? Should NIV be offered to patients with MND? If so when?
More informationThe term cor pulmonale is still very popular in the medical literature, but its definition varies
Correspondence to: Professor Emmanuel Weitzenblum, Service de Pneumologie, Hôpital de Hautepierre, 67098 Strasbourg Cedex, France; emmanuel.weitzenblum@ chru-strasbourg.fr c DEFINITIONS General cardiology
More informationOxygen treatment of sleep hypoxaemia in Duchenne
Thorax 1989;44:997-1001 Oxygen treatment of sleep hypoxaemia in Duchenne muscular dystrophy P E M SMITH, R H T EDWARDS, P M A CALVERLEY From the Muscle Research Centre, University Department ofmedicine
More informationRon Hosp, MS-HSA, RRT Regional Respiratory Specialist. This program has been approved for 1 hour of continuing education credit.
Ron Hosp, MS-HSA, RRT Regional Respiratory Specialist This program has been approved for 1 hour of continuing education credit. Course Objectives Identify at least four goals of home NIV Identify candidates
More informationOverlap Syndrome. José M. Marin Hospital Universitario Miguel Servet Zaragoza, Spain.
Overlap Syndrome José M. Marin Hospital Universitario Miguel Servet Zaragoza, Spain. I have nothing to disclose. Agenda Effects of sleep on breathing Sleep in COPD The Overlap Syndrome Treatment of the
More informationSHORT TERM EFFECTS OF NIV ON SLEEP IN END STAGE CF. Moran Lavie MD The national center for Cystic Fibrosis Sheba medical center
SHORT TERM EFFECTS OF NIV ON SLEEP IN END STAGE CF Moran Lavie MD The national center for Cystic Fibrosis Sheba medical center Sleeping with CF (1) In CF, sleep can place a significant physiologic load
More informationIncreasing the Functional Residual Capacity May Reverse Obstructive Sleep Apnea
Sleep 11(4):349-353, Raven Press, Ltd., New York 1988 Association of Professional Sleep Societies ncreasing the Functional Residual Capacity May Reverse Obstructive Sleep Apnea F. Series, Y. Cormier, N.
More informationDoes long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?
Eur Respir J 2002; 20: 38 42 DOI: 10.1183/09031936.02.00284202 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Does long-term oxygen therapy
More informationsubjects Arousal responses to added inspiratory resistance during REM and non-rem sleep in normal M Gugger, S B6gershausen, L Schaffler
Thorax 1993;48:125-129 Division of Pneumology M Gugger S Bogershausen Department of Neurology, University of Berne, Inselspital, CH-31 Berne, Switzerland L Schaffler Reprint requests to: Dr M Gugger Received
More informationObstructive sleep apnea (OSA) is the periodic reduction
Obstructive Sleep Apnea and Oxygen Therapy: A Systematic Review of the Literature and Meta-Analysis 1 Department of Anesthesiology, Toronto Western Hospital, University Health Network, University of Toronto,
More informationPEDIATRIC OBSTRUCTIVE SLEEP APNEA (OSA)
PEDIATRIC OBSTRUCTIVE SLEEP APNEA (OSA) DEFINITION OSA Inspiratory airflow is either partly (hypopnea) or completely (apnea) occluded during sleep. The combination of sleep-disordered breathing with daytime
More informationMario Kinsella MD FAASM 10/5/2016
Mario Kinsella MD FAASM 10/5/2016 Repetitive episodes of apnea or reduced airflow Due to upper airway obstruction during sleep Patients often obese Often have hypertension or DM 1 Obstructive apneas, hypopneas,
More informationRespiratory disturbance during sleep in chronic obstructive pulmonary disease*
Respiratory disturbance during sleep in chronic obstructive pulmonary disease* Perturbação respiratória durante o sono em doença pulmonar obstrutiva crônica ANA C. KRIEGER Chronic obstructive pulmonary
More information1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation.
Chapter 1: Principles of Mechanical Ventilation TRUE/FALSE 1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation. F
More informationObjectives. Health care significance of ARF 9/10/15 TREATMENT OF ACUTE RESPIRATORY FAILURE OF VARIABLE CAUSES: INVASIVE VS. NON- INVASIVE VENTILATION
TREATMENT OF ACUTE RESPIRATORY FAILURE OF VARIABLE CAUSES: INVASIVE VS. NON- INVASIVE VENTILATION Louisa Chika Ikpeama, DNP, CCRN, ACNP-BC Objectives Identify health care significance of acute respiratory
More informationSleep Abnormalities and Treatment in Emphysema
Sleep Abnormalities and Treatment in Emphysema Samuel Krachman 1, Omar A. Minai 2, and Steven M. Scharf 3 1 Sleep Disorders Center, Division of Pulmonary and Critical Care, Temple University School of
More informationThe most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome
The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome Natsios Georgios University Hospital of Larissa, Greece Definitions Obstructive Sleep Apnea (OSA)
More informationDiagnostic and therapeutic approach to coexistent chronic obstructive pulmonary disease and obstructive sleep apnea
REVIEW Diagnostic and therapeutic approach to coexistent chronic obstructive pulmonary disease and obstructive sleep apnea Sanja Jelic Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia
More informationObjectives. Apnea Definition and Pitfalls. Pathophysiology of Apnea. Apnea of Prematurity and hypoxemia episodes 5/18/2015
Apnea of Prematurity and hypoxemia episodes Deepak Jain MD Care of Sick Newborn Conference May 2015 Objectives Differentiating between apnea and hypoxemia episodes. Pathophysiology Diagnosis of apnea and
More informationPUBLISHED VERSION.
PUBLISHED VERSION McDonald, Christine F.; Crockett, Alan Joseph; Young, Iven H. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand Medical Journal
More informationKey words: control of breathing; pulmonary diseases, chronic obstructive; hypercapnia; respiratory muscle function; survival
Survival of Chronic Hypercapnic COPD Patients Is Predicted by Smoking Habits, Comorbidity, and Hypoxemia* Tessa A. C. Nizet, MD; Frank J. J. van den Elshout, MD, PhD; Yvonne F. Heijdra, MD, PhD; Marjo
More informationG. Sampol*, M.T. Sagalés**, A. Roca*, M.D. de la Calzada**, J.M. Bofill*, F. Morell*
Eur Respir J, 1996, 9, 111 116 DOI: 10.1183/09031936.96.09010111 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Nasal continuous positive
More informationBTS sleep Course. Module 10 Therapies I: Mechanical Intervention Devices (Prepared by Debby Nicoll and Debbie Smith)
BTS sleep Course Module 10 Therapies I: Mechanical Intervention Devices (Prepared by Debby Nicoll and Debbie Smith) S1: Overview of OSA Definition History Prevalence Pathophysiology Causes Consequences
More informationLong-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD
Eur Respir J 2004; 23: 825 831 DOI: 10.1183/09031936.04.00085804 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2004 European Respiratory Journal ISSN 0903-1936 Long-acting inhaled anticholinergic
More informationRespiratory Failure. Causes of Acute Respiratory Failure (ARF): a- Intrapulmonary:
Respiratory failure exists whenever the exchange of O 2 for CO 2 in the lungs cannot keep up with the rate of O 2 consumption & CO 2 production in the cells of the body. This results in a fall in arterial
More informationUsing the Pathophysiology of Obstructive Sleep Apnea (OSA) to Teach Cardiopulmonary Integration
Using the Pathophysiology of Obstructive Sleep Apnea (OSA) to Teach Cardiopulmonary Integration Michael G. Levitzky, Ph.D. Department of Physiology Louisiana State University Health Sciences Center 1901
More informationAssessment and Interpretation of Arterial Oxygen Saturation in Children with Cystic Fibrosis
Assessment and Interpretation of Arterial Oxygen Saturation in Children with Cystic Fibrosis Donald Urquhart, MB, ChB Portex Unit of Anaesthesia, Intensive Care, and Respiratory Medicine Institute of Child
More informationChronic NIV in heart failure patients: ASV, NIV and CPAP
Chronic NIV in heart failure patients: ASV, NIV and CPAP João C. Winck, Marta Drummond, Miguel Gonçalves and Tiago Pinto Sleep disordered breathing (SDB), including OSA and central sleep apnoea (CSA),
More informationAccess to the published version may require journal subscription. Published with permission from: Blackwell Synergy
This is an author produced version of a paper published in Clinical Physiology and Functional Imaging. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal
More informationOxygen Therapy: When, What and Why
Oxygen Therapy: When, What and Why SOUTH EAST LONDON OXYGEN STUDY DAY 26/5/2016 Dr Irem Patel, Integrated Respiratory Physician, King s Health Partners Oxygen: A medicine to treat hypoxia What I will cover
More informationLecture Notes. Chapter 2: Introduction to Respiratory Failure
Lecture Notes Chapter 2: Introduction to Respiratory Failure Objectives Define respiratory failure, ventilatory failure, and oxygenation failure List the causes of respiratory failure Describe the effects
More informationTSANZ meeting 01 Apr Physiology of respiratory failure in COPD & OHS. Bhajan Singh MBBS FRACP PhD
TSANZ meeting 01 Apr 2015 Physiology of respiratory failure in & OHS Bhajan Singh MBBS FRACP PhD Head of Department, Pulmonary Physiology & Sleep Medicine, Sir Charles Gairdner Hospital Director, West
More informationPatient ventilator asynchrony and sleep disruption during noninvasive
Review Article Patient ventilator asynchrony and sleep disruption during noninvasive ventilation Michelle Ramsay Lane Fox Unit, St Thomas Hospital, London, UK Correspondence to: Dr. Michelle Ramsay, MRCP
More informationPEDIATRIC SLEEP GUIDELINES Version 1.0; Effective
MedSolutions, Inc. Clinical Decision Support Tool Diagnostic Strategies This tool addresses common symptoms and symptom complexes. Requests for patients with atypical symptoms or clinical presentations
More informationRespiratory Pathophysiology Cases Linda Costanzo Ph.D.
Respiratory Pathophysiology Cases Linda Costanzo Ph.D. I. Case of Pulmonary Fibrosis Susan was diagnosed 3 years ago with diffuse interstitial pulmonary fibrosis. She tries to continue normal activities,
More informationNovel pathophysiological concepts for the development and impact of sleep apnea in CHF.
Olaf Oldenburg Novel pathophysiological concepts for the development and impact of sleep apnea in CHF. Sleep apnea the need to synchronize the heart, the lung and the brain. Heart Failure 2011 Gothenburg,
More informationUp to 50% of continuous flow oxygen therapy patients experience clinically significant nocturnal desaturation. 1
Up to 50% of continuous flow oxygen therapy patients experience clinically significant nocturnal desaturation. 1 Continuous Flow Oxygen Delivery & Sleep A number of theories and studies are published surrounding
More informationPolicy Specific Section: October 1, 2010 January 21, 2013
Medical Policy Bi-level Positive Airway Pressure (BPAP/NPPV) Type: Medical Necessity/Not Medical Necessity Policy Specific Section: Durable Medical Equipment Original Policy Date: Effective Date: October
More information3. Which of the following would be inconsistent with respiratory alkalosis? A. ph = 7.57 B. PaCO = 30 mm Hg C. ph = 7.63 D.
Pilbeam: Mechanical Ventilation, 4 th Edition Test Bank Chapter 1: Oxygenation and Acid-Base Evaluation MULTIPLE CHOICE 1. The diffusion of carbon dioxide across the alveolar capillary membrane is. A.
More informationBTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012
BTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012 Evidence base for Home Oxygen therapy in COPD, non-copd respiratory disease and nonrespiratory
More informationThe Effect of Sleep Disordered Breathing on Cardiovascular Disease
The Effect of Sleep Disordered Breathing on Cardiovascular Disease Juan G. Flores MD Pulmonary, Critical Care and Sleep Medicine Dupage Medical Group Director of Edward Sleep Lab Disclaimers or Conflicts
More informationInterpretation of Arterial Blood Gases. Prof. Dr. W. Vincken Head Respiratory Division Academisch Ziekenhuis Vrije Universiteit Brussel (AZ VUB)
Interpretation of Arterial Blood Gases Prof. Dr. W. Vincken Head Respiratory Division Academisch Ziekenhuis Vrije Universiteit Brussel (AZ VUB) Before interpretation of ABG Make/Take note of Correct puncture
More informationExercise Stress Testing: Cardiovascular or Respiratory Limitation?
Exercise Stress Testing: Cardiovascular or Respiratory Limitation? Marshall B. Dunning III, Ph.D., M.S. Professor of Medicine & Physiology Medical College of Wisconsin What is exercise? Physical activity
More informationIdentification and Treatment of the Patient with Sleep Related Hypoventilation
Identification and Treatment of the Patient with Sleep Related Hypoventilation Hillary Loomis-King, MD Pulmonary and Critical Care of NW MI Munson Sleep Disorders Center X Conflict of Interest Disclosures
More informationPediatric Sleep-Disordered Breathing
Pediatric Sleep-Disordered Breathing OSA in infants and young children is generally characterized by partial, persistent obstruction of the upper airway Continuum Benign primary snoring Upper-airway resistance
More information2/13/2018 OBESITY HYPOVENTILATION SYNDROME
OBESITY HYPOVENTILATION SYNDROME David Claman, MD UCSF Professor of Medicine Director, UCSF Sleep Disorders Center Disclosures: None. 1 COMPLICATIONS OF OSA Cardiovascular HTN, CHF, CVA, arrhythmia, Pulm
More informationAverage volume-assured pressure support
Focused review Average volume-assured pressure support Abdurahim Aloud MD Abstract Average volume-assured pressure support (AVAPS) is a relatively new mode of noninvasive positive pressure ventilation
More informationObstructive Sleep Apnoea and COPD: Can we use auto-titrating ventilator devices?
Obstructive Sleep Apnoea and COPD: Can we use auto-titrating ventilator devices? Dr. Patrick B. Murphy Lane Fox Unit, Guy s & St Thomas Hospital Westminster Bridge Rd SE1 7EH London UNITED KINGDOM patrick.murphy@gstt.nhs.uk
More informationRespiratory Failure how the respiratory physicians deal with airway emergencies
Respiratory Failure how the respiratory physicians deal with airway emergencies Dr Michael Davies MD FRCP Consultant Respiratory Physician Respiratory Support and Sleep Centre Papworth Hospital NHS Foundation
More informationIndex. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acquired central hypoventilation syndrome, NPPV in children with, 475 Acute cardiogenic pulmonary edema, PAP therapy in, 394 395 Adaptive
More informationpulmonale complicating chronic bronchitis and emphysema
Thorax (1976), 31, 414. Long-term domiciliary oxygen therapy in cor pulmonale complicating chronic bronchitis and emphysema R. J. LEGGETT, N. J. COOKE', L. CLANCY2, A. G. LEITCH, B. J. KIRBY3, and D. C.
More informationAir or oxygen as driving gas for nebulised salbutamol
Archives of Disease in Childhood, 1988, 63, 9-94 Air or oxygen as driving gas for nebulised salbutamol J G A GLEESON, S GREEN, AND J F PRICE Paediatric Respiratory Laboratory, Department of Thoracic Medicine,
More informationChronic Obstructive Pulmonary Disease
136 PHYSIOLOGY CASES AND PROBLEMS Case 24 Chronic Obstructive Pulmonary Disease Bernice Betweiler is a 73-year-old retired seamstress who has never been married. She worked in the alterations department
More informationHypoxic and hypercapnic response in asthmatic
Hypoxic and hypercapnic response in asthmatic subjects with previous respiratory failure ARLENE A HUTCHISON, ANTHONY OLINSKY From the Department of Thoracic Medicine, Royal Children's Hospital, Melbourne,
More informationA Comparison of Nocturnal Hypoxia Markers in Apnea Patients with Chronic Obstructive Pulmonary Disease and without it: A Cross-sectional Study
Original Research A Comparison of Nocturnal Hypoxia Markers in Apnea Patients with Chronic Obstructive Pulmonary Disease and without it: A Cross-sectional Study Fariborz Rezaeitalab 1, Hadi Asadpour 2,
More informationUniversity, India.) Corresponding author: Dr. Shubham Agarwal1
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 3 Ver.15 March. (2018), PP 59-63 www.iosrjournals.org Effect of Severity of OSA on Oxygen Saturation:
More informationA 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation
1 A 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation The following 3 minute polysomnogram (PSG) tracing was recorded in a 74-year-old man with severe ischemic cardiomyopathy
More informationRESPIRATION AND SLEEP AT HIGH ALTITUDE
MANO Pulmonologist-Intensivis Director of ICU and Sleep Dis Evangelism Ath RESPIRATION AND SLEEP AT HIGH ALTITUDE 2 nd Advanced Course in Mountain Medicine MAY 25-27 OLYMPUS MOUNTAIN Respiration Breathing
More informationSLEEP DISORDERED BREATHING AND CHRONIC LUNG DISEASE: UPDATE ON OVERLAP SYNDROMES
SLEEP DISORDERED BREATHING AND CHRONIC LUNG DISEASE: UPDATE ON OVERLAP SYNDROMES ROBERT OWENS, MD ASSISTANT CLINICAL PROFESSOR OF MEDICINE UNIVERSITY OF CALIFORNIA AT SAN DIEGO LA JOLLA, CA Robert L. Owens,
More informationOXYGEN USE IN PHYSICAL THERAPY PRACTICE. Rebecca H. Crouch, PT,DPT,MS,CCS,FAACVPR
OXYGEN USE IN PHYSICAL THERAPY PRACTICE Rebecca H. Crouch, PT,DPT,MS,CCS,FAACVPR Supplemental Oxygen Advantages British Medical Research Council Clinical Trial Improved survival using oxygen 15 hrs/day
More information6/5/2017. Mellar P Davis MD FCCP FAAHPM Geisinger Medical Center Danville, PA
Mellar P Davis MD FCCP FAAHPM Geisinger Medical Center Danville, PA Opioids adversely influence respiration in five distinct ways Opioids cause complex sleep disordered breathing consisting of central
More informationEffect of Metabolic Acidosis Upon Sleep Apnea*
Effect of Metabolic Upon Sleep Apnea* john T. Sharp, M.D., F.C.C.P.; WalterS. Druz, Ph.D.; Vivian D'Souza, M.D.; and Edward Diamond, M.D. The effects of metabolic acidosis upon the pattern of apnea during
More informationAnaesthesia and Morbid Obesity
Anaesthesia and Morbid Obesity Facts 20% adults Obese (1% Morbidly Obese) BMI >35 with comorbidity / BMI >40 without comorbidity = morbidly obese BMI > 55 = super-morbidly obese BMI > 30 rapid increase
More informationBiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT
BiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT Modes Continuous Positive Airway Pressure (CPAP): One set pressure which is the same on inspiration and expiration Auto-PAP (APAP) - Provides
More informationIndications for Respiratory Assistance. Sheba Medical Center, ICU Department Nick D Ardenne St George s University of London Tel Hashomer
Indications for Respiratory Assistance Sheba Medical Center, ICU Department Nick D Ardenne St George s University of London Tel Hashomer Respiratory Assistance Non-invasive - Nasal specs - Facemask/ Resevoir
More informationCritical Care Monitoring. Assessing the Adequacy of Tissue Oxygenation. Tissue Oxygenation - Step 1. Tissue Oxygenation
Critical Care Monitoring 1 Assessing the Adequacy of Tissue oxygenation is the end-product of many complex steps 2 - Step 1 Oxygen must be made available to alveoli 3 1 - Step 2 Oxygen must cross the alveolarcapillary
More informationOver the last several years various national and
Recommendations for the Management of COPD* Gary T. Ferguson, MD, FCCP Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American
More informationNew Government O2 Criteria and Expert Panel. Jennifer Despain, RPSGT, RST, AS
New Government O2 Criteria and Expert Panel Jennifer Despain, RPSGT, RST, AS Lead Sleep Technologist, Central Utah Clinic Sleep Disorders Center; Provo, Utah Objectives: Review new government O2 criteria
More information3/30/12. Luke J. Gasowski BS, BSRT, NREMT-P, FP-C, CCP-C, RRT-NPS
Luke J. Gasowski BS, BSRT, NREMT-P, FP-C, CCP-C, RRT-NPS 1) Define and describe ETCO 2 2) Explain methods of measuring ETCO 2 3) Describe various clinical applications of ETCO 2 4) Describe the relationship
More informationThe Familial Occurrence of Obstructive Sleep Apnoea Syndrome (OSAS)
Global Journal of Respiratory Care, 2014, 1, 17-21 17 The Familial Occurrence of Obstructive Sleep Apnoea Syndrome (OSAS) Piotr Bielicki, Tadeusz Przybylowski, Ryszarda Chazan * Department of Internal
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Obstructive sleep apnoea How to identify? Walter McNicholas MD Newman Professor in Medicine, St. Vincent s University Hospital, University College Dublin, Ireland. Potential
More informationSleep disorders in COPD: the forgotten dimension
REVIEW SLEEP AND BREATHING Sleep disorders in COPD: the forgotten dimension Walter T. McNicholas 1, Johan Verbraecken 2 and Jose M. Marin 3 Affiliations: 1 Pulmonary and Sleep Disorders Unit, St. Vincent
More informationCompetency Title: Continuous Positive Airway Pressure
Competency Title: Continuous Positive Airway Pressure Trainee Name: ------------------------------------------------------------- Title: ---------------------------------------------------------------
More informationArterial Blood Gas Analysis
Arterial Blood Gas Analysis L Lester www.3bv.org Bones, Brains & Blood Vessels Drawn from radial or femoral arteries. Invasive procedure Caution must be taken with patient on anticoagulants ph: 7.35-7.45
More informationPolysomnography (PSG) (Sleep Studies), Sleep Center
Policy Number: 1036 Policy History Approve Date: 07/09/2015 Effective Date: 07/09/2015 Preauthorization All Plans Benefit plans vary in coverage and some plans may not provide coverage for certain service(s)
More informationCor pulmonale. Dr hamid reza javadi
1 Cor pulmonale Dr hamid reza javadi 2 Definition Cor pulmonale ;pulmonary heart disease; is defined as dilation and hypertrophy of the right ventricle (RV) in response to diseases of the pulmonary vasculature
More informationSleep and the Heart. Sleep Stages. Sleep and the Heart: non REM 8/31/2016
Sleep and the Heart Overview of sleep Hypertension Arrhythmias Ischemic events CHF Pulmonary Hypertension Cardiac Meds and Sleep Sleep Stages Non-REM sleep(75-80%) Stage 1(5%) Stage 2(50%) Stage 3-4*(15-20%)
More information